NCI, Inc.
NCIT
NCIT was delisted on the 15th of August, 2017.
0 hedge funds and large institutions have $0 invested in NCI, Inc. in 2017 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 71 closing their positions.
100% less funds holding
Funds holding: 71 → 0 (-71)
100% less capital invested
Capital invested by funds: $121M → $0 (-$121M)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 71
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$19.6M |
| 2 |
RA
Royce & Associates
New York
|
-$14.3M |
| 3 |
BlackRock
New York
|
-$10.3M |
| 4 |
Renaissance Technologies
New York
|
-$10.3M |
| 5 |
Dimensional Fund Advisors
Austin,
Texas
|
-$6.6M |
NCIT Hedge Fund Activity: Q3 2017 in Review
0 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in NCI, Inc. (NCIT) for Q3 2017, worth a combined $0 — down 100% from $121M a quarter earlier.
Sellers outnumbered buyers: 71 funds closed out of NCIT and 0 opened new positions — a net loss of 71 holders — while 0 trimmed existing stakes and 0 added.
The largest seller was Fidelity Investments, exiting entirely with an estimated $19.6M sold.
- 0 institutional investors held NCI, Inc. (NCIT) as of Q3 2017, down from 71 in Q2 2017.
- Funds reported $0 of NCI, Inc. stock for Q3 2017, down 100% quarter-over-quarter.
- 0 funds opened new NCI, Inc. positions in Q3 2017 and 71 closed out, a net change of -71 holders.
- The largest NCI, Inc. seller in Q3 2017 was Fidelity Investments, an estimated $19.6M sold.
Based on aggregated 13F filings for Q3 2017.